The Genetics of Neuronal Channelopathies

Abstract

A channelopathy is a new mechanism of disease involving dysfunction of ion pumps and channels. Monogenic forms of common neuronal disease phenotypes – such as seizures, ataxia and migraine – have been demonstrated to be produced by mutation of such genes. The mutation serves to produce a constitutionally hyperexcitable tissue that is susceptible to periodic decompensations recognized as disease. There are suggestions that similar mechanisms are at play in the common polygenic forms of these diseases, and that an understanding of these a etiological genes hold the potential to lead to new diagnostics and therapeutics.

Keywords: channelopathy (channel disease); ion channel; genetic disease; seizures; migraine; ataxia

References

Barrett CF, Cao YQ and Tsien RW (2005) Gating deficiency in a familial hemiplegic migraine type 1 mutant P/Q‐type calcium channel. Journal of Biological Chemistry 280: 24064–24071.

Jentsch TJ (2000) Neuronal KCNQ potassium channels: physiology and role in disease. Nature Reviews Neuroscience 1: 21–30.

Kaja S, van de Ven RC, Broos LA et al. (2005) Gene dosage‐dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non‐progressive and do not lead to morphological changes or muscle weakness. Neuroscience 135: 81–95.

Kors EE, Melberg A, Vanmolkot KR et al. (2004) Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology 63: 1136–1137.

Lossin C, Wang DW, Rhodes TH, Vanoye CG and George AL Jr (2002) Molecular basis of an inherited epilepsy. Neuron 34: 877–884.

Ma S, Abou‐Khalil B, Blair MA et al. (2006) Mutations in GABRA1, GABRA5, GABRG2 and GABRD receptor genes are not a major factor in the pathogenesis of familial focal epilepsy preceded by febrile seizures. Neuroscience Letters 394: 74–78.

Ophoff RA, Terwindt GM, Vergouwe MN et al. (1996) Familial hemiplegic migraine and episodic ataxia type‐2 are caused by mutations in the Ca(2+) channel gene CACNL1A4. Cell 87: 543–552.

Segall L, Mezzetti A, Scanzano R et al. (2005) Alterations in the alpha2 isoform of Na,K‐ATPase associated with familial hemiplegic migraine type 2. Proceedings of the National Academy of Sciences of the USA 102: 11106–11111.

Splawski I, Timothy KW, Sharpe LM et al. (2004) Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119: 19–31.

Steinlein OK, Mulley JC, Propping P et al. (1995) A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nature Genetics 11: 201–203.

Tan HL (2006) Sodium channel variants in heart disease: expanding horizons. Journal of Cardiovascular Electrophysiology 17: S151–S157.

Tate SK, Depondt C, Sisodiya SM et al. (2005) Genetic predictors of the maximum doses patients receive during clinical use of the anti‐epileptic drugs carbamazepine and phenytoin. Proceedings of the National Academy of Sciences of the USA 102: 5507–5512.

The Human Gene Mutation database. http://www.hgmd.cf.ac.uk/ac/index.php

Wafford KA (2005) GABAA receptor subtypes: any clues to the mechanism of benzodiazepine dependence. Current Opinion in Pharmacology 5: 47–52.

Watanabe H, Nagata E, Kosakai A et al. (2000) Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability. Journal of Neurochemistry 75: 28–33.

Further Reading

Gargus JJ (2003) Unraveling monogenic channelopathies and their implications for complex polygenic disease. The American Journal of Human Genetics 72: 785–803.

Gargus JJ (2006) Ion channel functional candidate genes in multigenic neuropsychiatric disease. Biological Psychiatry 60: 177–185.

Harper CM (2004) Congenital myasthenic syndromes. Seminars in Neurology 24: 111–123.

Hille B (2001) Ion channels of excitable membranes, 3rd edn. Sunderland, MA: Sinauer Associates.

Marban E (2002) Cardiac channelopathies. Nature 415: 213–218.

Meisler MH and Kearney JA (2005) Sodium channel mutations in epilepsy and other neurological disorders. The Journal of Clinical Investigation 115: 2010–2017.

Mulley JC, Scheffer IE, Harkin LA, Berkovic SF and Dibbens LM (2005) Susceptibility genes for complex epilepsy. Human Molecular Genetics 14: R243–R249.

Pietrobon D (2005) Function and dysfunction of synaptic calcium channels: insights from mouse models. Current Opinion in Neurobiology 15: 257–265.

Surti TS and Jan LY (2005) A potassium channel, the M‐channel, as a therapeutic target. Current Opinion in Investigational Drugs 6: 704–711.

Vicart S, Sternberg D, Fontaine B and Meola G (2005) Human skeletal muscle sodium channelopathies. Neurological Sciences 26: 194–202.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Ma, Shaochun, and Gargus, John Jay(Jul 2007) The Genetics of Neuronal Channelopathies. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0020225]